Inotropes and vasopressors

Inotropes are medicines that strengthen the heart, and vasopressors are medicines that narrow blood vessels. MeSH describes cardiotonic agents as agents that strengthen the heart or increase cardiac output, and vasoconstrictor agents as drugs that constrict blood vessels. US labels call dobutamine an inotropic agent, milrinone a positive inotrope and vasodilator, and norepinephrine a peripheral vasoconstrictor and an inotropic stimulator of the heart. This is the class page.

Also called Inotropic agents · Positive inotropes · Cardiotonic agents · Vasopressor agents · Vasoconstrictor agents

  • Drug
  • In this atlas

Overview

Technical summary

Class page. Two MeSH descriptors, both broad matches because each covers only half of the page: D002316 (Cardiotonic Agents, strengthening effect on the heart or increased cardiac output, named uses after myocardial infarction and cardiac surgery, in shock and in heart failure) and D014662 (Vasoconstrictor Agents, drugs used to cause constriction of the blood vessels). Vasopressor Agents is a MeSH entry term of the second (read 2026-11-18, hash only). The three members are filed by label wording, not by RxClass: the labels read (Hikma milrinone lactate, ANDA077966; Baxter dobutamine in dextrose, NDA020255; Hospira Levophed, NDA007513) call the products a positive inotrope, an inotropic agent and an inotropic stimulator of the heart, and RxClass gives them three different pharmacologic classes (Phosphodiesterase 3 Inhibitor, beta-Adrenergic Agonist and Catecholamine), none of which is named for the inotrope effect. The milrinone label says milrinone differs in structure and mode of action from the digitalis group and from the catecholamines, so the class groups by effect, not by chemistry. The Levophed label lists raising blood pressure in adults with severe, acute hypotension. Statements are scoped to the labels read. No trial result and no dose is recorded.

Drugs in this class

3 drugs in this atlas are filed under Inotropes and vasopressors, with the registry trials and FDA regulatory decisions this atlas holds for each. With Inotropes and vasopressors itself, the class has 5 distinct trials and 11 distinct FDA decisions; a trial or decision that two of them share counts once there.

About this drug

Level
Class
Mechanism
The labels read describe a positive inotrope and vasodilator (milrinone), an inotropic agent acting on the beta-receptors of the heart (dobutamine) and a peripheral vasoconstrictor that is also an inotropic stimulator of the heart (norepinephrine).

Classification codes

  • MeSH id.nlm.nih.gov linked data, retrieved 2026-11-18 D002316
  • MeSH id.nlm.nih.gov linked data, retrieved 2026-11-18 D014662

Claims and evidence

No claims are published for this drug yet.

Record details

Record id
cardio:inotropes-and-vasopressors
Content hash
993998e64694dfbd469046da6c7a7fcc3e09bf4b4f3735087c4bafb9146d1493